Bribery and corruption
Novartis Group companies will not engage directly or indirectly in bribery. Bribery means to offer, promise or provide an undue benefit to a public official with the intention of obtaining or retaining an improper advantage by encouraging the official to act, or refrain from acting, in connection with an official duty. All activities of this nature are prohibited.
To ensure that our values are translated into action, we have established a global Integrity and Compliance program to monitor conformity with our standards, as addressed in the Novartis Code of Conduct, the Novartis guideline on business ethics and Novartis Pharma Principles and Practices for Professionals (NP4) Policy and Guidelines.
Our Business Practices Office confidentially handles complaints and allegations of misconduct.